Epizyme Inc. (NASDAQ: EPZM) Has Succeeded To Excite In 2021, The Stock Is Down -55.16% Year-To-Date – Marketing Sentinel
Home  »  Science   »  Epizyme Inc. (NASDAQ: EPZM) Has Succeeded To Excit...

Epizyme Inc. (NASDAQ: EPZM) Has Succeeded To Excite In 2021, The Stock Is Down -55.16% Year-To-Date

Epizyme Inc. (NASDAQ:EPZM)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting 1.19. At the close of trading, the stock’s price was $4.87, to imply a decrease of -1.42% or -$0.07 in intraday trading. The EPZM share’s 52-week high remains $14.30, putting it -193.63% down since that peak but still an impressive 3.08% since price per share fell to its 52-week low of $4.72. The company has a valuation of $491.24M, with an average of 0.72 million shares in intraday trading volume over the past 10 days and average of 997.04K shares over the past 3 months.

Analysts have given a consensus recommendation of an Overweight for Epizyme Inc. (EPZM), translating to a mean rating of 2.10. Of 7 analyst(s) looking at the stock, 1 analyst(s) give EPZM a Sell rating. 1 of those analysts rate the stock as Overweight while 1 advise Hold as 4 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.49.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Epizyme Inc. (NASDAQ:EPZM) trade information

After registering a -1.42% downside in the last session, Epizyme Inc. (EPZM) has traded red over the past five days. The stock hit a weekly high of 5.24 this Friday, 10/08/21, dropping -1.42% in its intraday price action. The 5-day price performance for the stock is -6.17%, and -14.26% over 30 days. With these gigs, the year-to-date price performance is -55.16%. Short interest in Epizyme Inc. (NASDAQ:EPZM) saw shorts transact 9.04 million shares and set a 9.03 days time to cover.

Analysts on Wall Street suggest a consensus price target of $11.14, implying an increase of 56.28% to the stock’s current value. The extremes give us $5.00 and $16.00 for target low and target high price respectively. As such, EPZM has been trading -228.54% off suggested target high and -2.67% from its likely low.

Epizyme Inc. (EPZM) estimates and forecasts

Looking at statistics comparing Epizyme Inc. share performance against respective industry, we note that the company has underperformed competitors. Epizyme Inc. (EPZM) shares are -40.02% down over the last 6 months, with its year-to-date growth rate lower than industry average at 6.11% against 7.00%. Revenue is forecast to grow 10.90% this quarter before jumping 44.60% for the next one. The rating firms project that company’s revenue will grow 265.40% compared to the previous financial year.

Revenue forecast for the current quarter as set by 6 analysts is $12.18 million. Meanwhile, for the quarter ending Dec 2021, a total of 6 analyst(s) estimate revenue growth to $22.97 million.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 7.10% for the past 5-year period. While 2021 is set for a -19.10% return in earnings, projections for the next 5 years are at 38.00% annually.

EPZM Dividends

Epizyme Inc. has its next earnings report out between November 04 and November 08. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Epizyme Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Epizyme Inc. (NASDAQ:EPZM)’s Major holders

Epizyme Inc. insiders hold 4.36% of total outstanding shares, with institutional holders owning 97.77% of the shares at 102.23% float percentage. In total, 97.77% institutions holds shares in the company, led by Primecap Management Company. As of Jun 29, 2021, the company held over 15.29 million shares (or 14.95% of shares), all amounting to roughly $127.04 million.

The next major institution holding the largest number of shares is RP Management, LLC with 9.17 million shares, or about 8.96% of shares outstanding. As of the market price on Jun 29, 2021, these shares were worth $76.18 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

We also have Primecap Odyssey Aggressive Growth Fund and Primecap Odyssey Growth Fund as the top two Mutual Funds with the largest holdings of the Epizyme Inc. (EPZM) shares. Going by data provided on Jul 30, 2021, Primecap Odyssey Aggressive Growth Fund holds roughly 9.79 million shares. This is just over 9.57% of the total shares, with a market valuation of $64.88 million. Data from the same date shows that the other fund manager holds a little less at 4.73 million, or 4.62% of the shares, all valued at about 31.34 million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts



Download Free eBook For



100% free. stop anytime no spam



Download Free eBook For



100% free. stop anytime no spam